Gene therapy

Gene therapies' accessibility problem

Adapted from PwC Health Research Institute; Graphic: Axios Visuals

Gene therapies are physically out of reach for many patients, on top of their cost, according to a new PwC Health Research Institute report.

Why it matters: This further exacerbates the rural-urban divide in access to care.

Genetic technology's double-edged sword

Illustration of breaking pencil erasing gene sequence
Illustration: Sarah Grillo/Axios

As gene-altering technologies become more accessible, there's also a growing risk that they'll be dangerously misused or abused.

Why it matters: "You're talking about manipulating DNA to create a designer pathogen. That’s a terrorist threat," former FDA Commissioner Scott Gottlieb told me.